Corvus Pharmaceuticals Chief Business Officer Jeffrey Arcara acquires 4,500 common shares for $50,475.215
CRVS•Corvus Pharmaceuticals Chief Business Officer Jeffrey Arcara purchased 4,500 common shares, bringing his direct holdings to 4,500 shares. The purchases were made at prices ranging from $10.37 to $11.4602 per share.
1. Share purchases
Jeffrey Arcara purchased 4,500 Corvus Pharmaceuticals common shares. The purchases included 3,000 shares at $11.4602 each, 497 at $11.115, 503 at $10.37 and 500 at $10.7087.
